Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 6
2005 4
2006 4
2007 7
2008 2
2009 7
2010 7
2011 9
2012 2
2013 9
2014 14
2015 11
2016 9
2017 15
2018 12
2019 10
2020 19
2021 29
2022 25
2023 37
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

212 results

Results by year

Filters applied: . Clear all
Page 1
Outdoor workers and sun exposure: Results of an international survey on sun exposure behaviours and knowledge among 17 countries, the HELIOS project.
Passeron T, Dreno B, Puig S, Goh CL, Kang HY, Ly F, Morita A, Ocampo Candiani J, Schalka S, Wei L, Demessant-Flavigny AL, Le Floc'h C, Kerob D, Lim HW, Krutmann J. Passeron T, et al. J Eur Acad Dermatol Venereol. 2024 Mar 30. doi: 10.1111/jdv.20001. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38553881 No abstract available.
Secukinumab in patients with moderate to severe hidradenitis suppurativa based on prior biologic exposure: An efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials.
Zouboulis CC, Passeron T, Pariser D, Wozniak MB, Li X, Uhlmann L, Lobach I, Martinez AL, Ravichandran S, Alarcon I, Offidani A, Alam MS, Mendes-Bastos P. Zouboulis CC, et al. Among authors: passeron t. Br J Dermatol. 2024 Mar 12:ljae098. doi: 10.1093/bjd/ljae098. Online ahead of print. Br J Dermatol. 2024. PMID: 38470171
Clinical Images: A Strange Reaction After a Hyaluronic Acid Injection.
Piroth M, Fanjat Y, Cardot-Leccia N, Roux C, Passeron T. Piroth M, et al. Among authors: passeron t. Arthritis Rheumatol. 2024 Feb 5. doi: 10.1002/art.42818. Online ahead of print. Arthritis Rheumatol. 2024. PMID: 38317300 No abstract available.
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
Maurer M, Ensina LF, Gimenez-Arnau AM, Sussman G, Hide M, Saini S, Grattan C, Fomina D, Rigopoulos D, Berard F, Canonica GW, Rockmann H, Irani C, Szepietowski JC, Leflein J, Bernstein JA, Peter JG, Kulthanan K, Godse K, Ardusso L, Ukhanova O, Staubach P, Sinclair R, Gogate S, Thomsen SF, Tanus T, Ye YM, Burciu A, Barve A, Modi D, Scosyrev E, Hua E, Letzelter K, Varanasi V, Patekar M, Severin T; PEARL-1 and PEARL-2 trial investigators. Maurer M, et al. Lancet. 2024 Jan 13;403(10422):147-159. doi: 10.1016/S0140-6736(23)01684-7. Epub 2023 Nov 23. Lancet. 2024. PMID: 38008109 Clinical Trial.
212 results